Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1864 1
1866 1
1872 1
1873 1
1887 1
1889 1
1901 1
1912 1
1914 1
1915 1
1918 1
1921 1
1924 2
1926 1
1927 3
1928 2
1929 2
1931 2
1932 3
1933 1
1934 2
1936 1
1937 1
1938 2
1941 1
1942 1
1944 2
1945 1
1946 4
1947 1
1948 4
1949 3
1950 4
1951 1
1952 1
1954 2
1955 1
1956 9
1957 6
1958 6
1959 6
1960 7
1961 7
1962 6
1963 5
1964 10
1965 8
1966 14
1967 9
1968 9
1969 15
1970 8
1971 13
1972 20
1973 29
1974 32
1975 32
1976 23
1977 29
1978 18
1979 24
1980 23
1981 24
1982 23
1983 26
1984 30
1985 39
1986 26
1987 31
1988 52
1989 48
1990 56
1991 46
1992 56
1993 58
1994 58
1995 54
1996 52
1997 50
1998 45
1999 49
2000 53
2001 83
2002 77
2003 76
2004 71
2005 122
2006 142
2007 147
2008 135
2009 115
2010 132
2011 137
2012 172
2013 134
2014 163
2015 165
2016 189
2017 216
2018 183
2019 199
2020 250
2021 294
2022 262
2023 22
Text availability
Article attribute
Article type
Publication date

Search Results

4,408 results
Results by year
Filters applied: . Clear all
Page 1
Antibody-Drug Conjugates for Cancer Therapy.
Hafeez U, Parakh S, Gan HK, Scott AM. Hafeez U, et al. Among authors: scott am. Molecules. 2020 Oct 16;25(20):4764. doi: 10.3390/molecules25204764. Molecules. 2020. PMID: 33081383 Free PMC article. Review.
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
Hofman MS, Emmett L, Sandhu S, Iravani A, Joshua AM, Goh JC, Pattison DA, Tan TH, Kirkwood ID, Ng S, Francis RJ, Gedye C, Rutherford NK, Weickhardt A, Scott AM, Lee ST, Kwan EM, Azad AA, Ramdave S, Redfern AD, Macdonald W, Guminski A, Hsiao E, Chua W, Lin P, Zhang AY, McJannett MM, Stockler MR, Violet JA, Williams SG, Martin AJ, Davis ID; TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Hofman MS, et al. Among authors: scott am. Lancet. 2021 Feb 27;397(10276):797-804. doi: 10.1016/S0140-6736(21)00237-3. Epub 2021 Feb 11. Lancet. 2021. PMID: 33581798 Clinical Trial.
Occupational therapy for cognitive impairment in stroke patients.
Gibson E, Koh CL, Eames S, Bennett S, Scott AM, Hoffmann TC. Gibson E, et al. Among authors: scott am. Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD006430. doi: 10.1002/14651858.CD006430.pub3. Cochrane Database Syst Rev. 2022. PMID: 35349186 Review.
Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas.
Sweha SR, Chung C, Natarajan SK, Panwalkar P, Pun M, Ghali A, Bayliss J, Pratt D, Shankar A, Ravikumar V, Rao A, Cieslik M, Wilder-Romans K, Scott AJ, Wahl DR, Jessa S, Kleinman CL, Jabado N, Mackay A, Jones C, Martinez D, Santi M, Judkins AR, Yadav VN, Qin T, Phoenix TN, Koschmann CJ, Baker SJ, Chinnaiyan AM, Venneti S. Sweha SR, et al. Among authors: scott aj. Sci Transl Med. 2021 Oct 13;13(615):eabf7860. doi: 10.1126/scitranslmed.abf7860. Epub 2021 Oct 13. Sci Transl Med. 2021. PMID: 34644147 Free PMC article.
Medical imaging and nuclear medicine: a Lancet Oncology Commission.
Hricak H, Abdel-Wahab M, Atun R, Lette MM, Paez D, Brink JA, Donoso-Bach L, Frija G, Hierath M, Holmberg O, Khong PL, Lewis JS, McGinty G, Oyen WJG, Shulman LN, Ward ZJ, Scott AM. Hricak H, et al. Among authors: scott am. Lancet Oncol. 2021 Apr;22(4):e136-e172. doi: 10.1016/S1470-2045(20)30751-8. Epub 2021 Mar 4. Lancet Oncol. 2021. PMID: 33676609 Free PMC article. Review.
Population-scale tissue transcriptomics maps long non-coding RNAs to complex disease.
de Goede OM, Nachun DC, Ferraro NM, Gloudemans MJ, Rao AS, Smail C, Eulalio TY, Aguet F, Ng B, Xu J, Barbeira AN, Castel SE, Kim-Hellmuth S, Park Y, Scott AJ, Strober BJ; GTEx Consortium; Brown CD, Wen X, Hall IM, Battle A, Lappalainen T, Im HK, Ardlie KG, Mostafavi S, Quertermous T, Kirkegaard K, Montgomery SB. de Goede OM, et al. Among authors: scott aj. Cell. 2021 May 13;184(10):2633-2648.e19. doi: 10.1016/j.cell.2021.03.050. Epub 2021 Apr 16. Cell. 2021. PMID: 33864768 Free PMC article.
Tumor-initiating stem cell shapes its microenvironment into an immunosuppressive barrier and pro-tumorigenic niche.
He X, Smith SE, Chen S, Li H, Wu D, Meneses-Giles PI, Wang Y, Hembree M, Yi K, Zhao X, Guo F, Unruh JR, Maddera LE, Yu Z, Scott A, Perera A, Wang Y, Zhao C, Bae K, Box A, Haug JS, Tao F, Hu D, Hansen DM, Qian P, Saha S, Dixon D, Anant S, Zhang D, Lin EH, Sun W, Wiedemann LM, Li L. He X, et al. Among authors: scott a. Cell Rep. 2021 Sep 7;36(10):109674. doi: 10.1016/j.celrep.2021.109674. Cell Rep. 2021. PMID: 34496236 Free PMC article.
4,408 results